Heart rate - predictor of cardiovascular risk;Srčana frekvencija - prediktor rizika od kardiovaskularnih bolesti

Vojnosanitetski Pregled

Volumn 69, Issue 9, 2012, Pages 799-802

  Ivanović, Branislava A ^a   Tadić, Marijana ^a   Dinčić, Dragan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiovascular diseases; Heart rate; Mortality; Prognosis; Risk factors

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE;

ADVERSE OUTCOME; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HEART RATE; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREDICTION; RESTING HEART RATE; RISK ASSESSMENT; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; TACHYCARDIA;

EID: 84866000750     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1209799I     Document Type: Article

References (27)

1. Levy RL, White PD, Stroud WD, Hillman CC. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945; 129: 585-8.
2. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112(6): 736-49.
3. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113(6): 1489-94.
4. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetière P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352(19): 1951-8.
5. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159(6): 585-92.
6. Tverdal A, Hjellvik V, Selmer R. Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years. Eur Heart J 2008; 29(22): 2772-81.
7. Hsia J, Larson JC, Ockene JK, Sarto GE, Allison MA, Hendrix SL, et al. Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ 2009; 338: b219.
8. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26(10): 967-74.
9. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990 Mar 1;65(9):547-53.
10. Kolloch R, Legler UF, Champion A, Cooper-Dehoff RM, Handberg E, Zhou Q, et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). Eur Heart J 2008; 29(10): 1327-34.
11. Palatini P, Thijs L, Staessen JA, Fagard RH, Bulpitt CJ, Clement DL, et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162(20): 2313-21.
12. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation 2000; 101(22): 2557-67.
13. Marchioli R, Avanzini F, Barzi F, Chieffo C, Di Castelnuovo A, Franzosi MG, et al. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001; 22(22): 2085-103.
14. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125(4): 1148-54.
15. Julius S, Palatini P, Kjeldsen SE, Zanchetti A, Weber MA, McInnes GT, et al. Tachycardia predicts CV events in the VALUE trial. American Society of Hypertension 2010 Scientific Meeting; May 1-4, 2010; New York, NY. Abstract LB-OR-01
16. Zamorano JL. Heart rate management: a therapeutic goal throughout the cardiovascular continuum. Eur Heart J Suppl 2008; 10(Suppl F): F17-F21.
17. Giannoglou GD, Chatzizisis YS, Zamboulis C, Parcharidis GE, Mikhailidis DP, Louridas GE. Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol 2008; 126(3): 302-12.
18. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14(7): 897-901.
19. Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007; 50(9): 823-30.
20. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper G 4th, et al. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. Circulation 2000; 101(6): 653-9.
21. Kjekshus JK. Importance of heart rate in determining betablocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57(12): 43F-9F.
22. Cucherat M. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in postmyocardial infarction: a meta-regression of randomized clinical trials. Eur Heart J 2007; 28(24): 3012-9.
23. Flannery G, Gehrig-Mills R, Billah B, Krum H. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 2008; 101(6): 865-9.
24. Huang RL, Listerman J, Goring J, Giesberg C, Nading MA, Butler J. Beta-blocker therapy for heart failure: should the therapeutic target be dose or heart rate reduction? Congest Heart Fail 2006; 12(4): 206-10; quiz 211-2.
25. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25(6): 1105-87.
26. Bangalore S, Sawhney S, Messerli FH. Relation of beta-blockerinduced heart rate lowering and cardioprotection in hypertension. J Am Coll Cardiol 2008; 52(18): 1482-9.
27. Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008; 372(9641): 817-21.